Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson’s disease

被引：0
|
作者：
Tarik Yonguc
Ertugrul Sefik
Ipek Inci
Ozge Yılmaz Kusbeci
Serdar Celik
Mehmet Erhan Aydın
Salih Polat
机构：
[1] Health Sciences University,Department of Urology
[2] Bozyaka Training and Research Hospital,Department of Neurology
[3] Health Sciences University,Department of Urology
[4] Bozyaka Training and Research Hospital,undefined
[5] Amasya University Sabuncuoglu Serefeddin Training and Research Hospital,undefined
来源：
World Journal of Urology | 2020年 / 38卷
关键词：
Incontinence; Overactive bladder; Fesoterodine fumarate; Cognitive functions; Parkinson’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2013 / 2019
页数：6
相关论文
共 50 条
  • [1] Randomized, controlled trial of fesoterodine fumarate for overactive bladder in Parkinson's disease
    Yonguc, Tarik
    Sefik, Ertugrul
    Inci, Ipek
    Kusbeci, Ozge Yilmaz
    Celik, Serdar
    Aydin, Mehmet Erhan
    Polat, Salih
    [J]. WORLD JOURNAL OF UROLOGY, 2020, 38 (08) : 2013 - 2019
  • [2] Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease
    Zesiewicz, Theresa A.
    Evatt, Marian
    Vaughan, Camille P.
    Jahan, Israt
    Singer, Carlos
    Ordorica, Raul
    Salemi, Jason L.
    Shaw, Jessica D.
    Sullivan, Kelly L.
    [J]. PARKINSONISM & RELATED DISORDERS, 2015, 21 (05) : 514 - 520
  • [3] Evaluation of fesoterodine fumarate for the treatment of an overactive bladder
    Mock, Stephen
    Dmochowski, Roger R.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1659 - 1666
  • [4] The safety and effectiveness of mirabegron in Parkinson's disease patients with overactive bladder: a randomized controlled trial
    Moussa, Mohamad
    Abou Chakra, Mohamad
    Dabboucy, Baraa
    Fares, Youssef
    Dellis, Athanasios
    Papatsoris, Athanasios
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2022, 56 (01) : 66 - 72
  • [5] New Perspectives of Treatment With Fesoterodine Fumarate in Patients With Overactive Bladder
    Garcia-Baquero, R.
    Madurga, B.
    Garcia, M. V.
    Fernandez, M. A.
    Rosety, J. M.
    Alvarez-Ossorio, J. L.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (02): : 83 - 91
  • [6] Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double-blind, randomized placebo-controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study)
    Cho, Sung Yong
    Jeong, Seong Jin
    Lee, Sangchul
    Kim, Janghwan
    Lee, Seong Ho
    Choo, Min Soo
    Oh, Seung-June
    [J]. NEUROUROLOGY AND URODYNAMICS, 2021, 40 (01) : 286 - 294
  • [7] Acupuncture for Overactive Bladder A Randomized Controlled Trial
    Bijak, Michaela
    [J]. DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2006, 49 (01): : 46 - +
  • [8] Acupuncture for overactive bladder - A randomized controlled trial
    Emmons, SL
    Otto, L
    [J]. OBSTETRICS AND GYNECOLOGY, 2005, 106 (01): : 138 - 143
  • [9] Acupuncture for Overactive Bladder — A Randomized Controlled Trial
    Michaela Bijak
    [J]. Deutsche Zeitschrift für Akupunktur, 2006, 49 (1) : 46 - 47
  • [10] Randomized, Double-Blind, Placebo-Controlled Trial of Flexible-Dose Fesoterodine in Subjects With Overactive Bladder
    Kaplan, Steven A.
    [J]. JOURNAL OF UROLOGY, 2011, 186 (03): : 993 - 994
12345